TERT and cancer: In recent studies, new staging/risk stratification systems or classifications of DTC incorporating TERT promoter mutation have shown improved predictability of recurrence or cancer-specific survival (CSS) [17–19], which emphasized the prognostic value of TERT promoter mutations in DTC.